LAURENCE LEON DENNIS

Allopathic & Osteopathic Physicians|Internal Medicine BOONEVILLE, MS NPI 1760466262

General Payments — all program years on this page

$4,023.95

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 275
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $393.40 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $393.4022

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $768.3456
2019 $626.8351
2020 $599.0842
2021 $762.9045
2022 $535.2837
2023 $338.1222
2024 $393.4022

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096861463 Novo Nordisk Inc $16.12 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097193283 Novo Nordisk Inc $15.56 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103625482 ABBVIE INC. $19.13 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103625484 ABBVIE INC. $22.35 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104600218 AstraZeneca Pharmaceuticals LP $13.57 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104786652 AstraZeneca Pharmaceuticals LP $34.31 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105878275 AstraZeneca Pharmaceuticals LP $13.13 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111561877 Amgen Inc. $15.00 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111561879 Amgen Inc. $16.32 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116098460 GlaxoSmithKline, LLC. $14.99 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116242221 GlaxoSmithKline, LLC. $15.82 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116291168 GlaxoSmithKline, LLC. $14.99 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116531540 GlaxoSmithKline, LLC. $14.99 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116672718 GlaxoSmithKline, LLC. $14.99 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117237346 Amgen Inc. $14.31 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117237348 Amgen Inc. $14.06 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117237350 Amgen Inc. $13.24 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118884125 Otsuka America Pharmaceutical, Inc. $19.02 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131012876 PFIZER INC. $20.23 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148298172 Axsome Therapeutics, Inc. $28.51 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148844461 Sumitomo Pharma America, Inc. $27.18 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151054995 Phathom Pharmaceuticals, Inc. $15.58 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.